Modified FOLFOX6 With or Without Radiation Versus Fluorouracil and Leucovorin With Radiation in Neoadjuvant Treatment of Locally Advanced Rectal Cancer: Initial Results of the Chinese FOWARC Multicenter, Open-Label, Randomized Three-Arm Phase III TrialYanhong Deng, Jianping Wang, Pan Chi et al.|Journal of Clinical Oncology|2016Cited by 409
Finotonlimab (PD-1 inhibitor) plus bevacizumab (bevacizumab biosimilar) as first-tier therapy for late-stage hepatocellular carcinoma: a randomized phase 2/3 trialChuanhua Zhao, Chuan Jin, Zhuang Li et al.|Signal Transduction and Targeted Therapy|2025Cited by 20
Modified FOLFOX6 with or without radiation in neoadjuvant treatment of locally advanced rectal cancer: Final results of the Chinese FOWARC multicenter randomized trial.Yanhong Deng, Jianping Wang, Pan Chi et al.|Journal of Clinical Oncology|2018Cited by 18